Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye.
Location: United States, California, Irvine
Employees: 11-50
Total raised: $60M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Visionary ... | visionaryv... |
| - | Aperture V... | aperturevp... |
| - | Frazier Li... | frazierls.... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.01.2020 | Series B | $60M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 15.03.2024 | This Chewable Tablet Can Protect Humans From Lyme Disease Br... | Joseph Henry, Tech Times 15 March 2024, 01:03 pm If you're a dog or cat owner, you know they are not... | techtimes.... |
| 05.03.2024 | Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilan... | - | globenewsw... |
| 10.08.2023 | Tarsus Reports Second Quarter 2023 Financial Results and Rec... | XDEMVY™ (lotilaner ophthalmic solution) 0.25% received FDA approval for the treatment for Demodex bl... | einpresswi... |
| 02.02.2022 | Tarsus Pharmaceuticals, Inc. Secures $175 Million Credit Fac... | Tarsus Pharmaceuticals, Inc. executed a $175 million credit facility with Hercules Capital, Inc. and... | marketscre... |
| 21.06.2021 | TARSUS PHARMACEUTICALS, INC. Tarsus Pharmaceuticals : Annou... | Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 Pivotal Trial Evaluating TP-03 f... | marketscre... |
| 24.05.2021 | TARSUS PHARMACEUTICALS, INC. Tarsus Pharmaceuticals, Inc. t... | IRVINE, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late... | marketscre... |
| 31.03.2021 | TARSUS PHARMACEUTICALS, INC. Tarsus Pharmaceuticals, Inc. R... | Enrollment complete for Saturn-1, first TP-03 pivotal trial for the treatment of Demodex blepharitis... | marketscre... |
| 16.01.2020 | Clinical-Stage Biopharmaceutical Company Tarsus Pharmaceutic... | Clinical-stage biopharmaceutical company Tarsus Pharmaceuticals announced it raised $60 million in S... | pulse2.com... |
| 08.01.2020 | Tarsus Pharmaceuticals Raises $60M in Series B | IRVINE, CA, Clinical-stage biopharmaceutical company, today announced the completion of $60 millio... | vcnewsdail... |
| 08.01.2020 | Tarsus Pharmaceuticals Secures $60M in Series B Financing | Tarsus Pharmaceuticals, an Irvine, Calif.-based clinical-stage biopharmaceutical company, closed a $... | finsmes.co... |